Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Markella V. Zanni, M.D.

Concepts (278)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Markella Zanni's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Markella Zanni has written about over time.
Macrophage Activation, 3 publications between 2012 and 2014, average publication date February 2013. Antigens, Differentiation, Myelomonocytic, 4 publications between 2012 and 2019, average publication date November 2015. Arteritis, 3 publications between 2014 and 2017, average publication date January 2016. Asymptomatic Diseases, 4 publications between 2016 and 2018, average publication date May 2017. Monocytes, 7 publications between 2012 and 2022, average publication date February 2019. Plaque, Atherosclerotic, 18 publications between 2013 and 2024, average publication date July 2019. Heart Failure, Diastolic, 1 publications between 2019 and 2019, average publication date September 2019. Anti-Retroviral Agents, 10 publications between 2014 and 2023, average publication date October 2019. Atherosclerosis, 8 publications between 2012 and 2024, average publication date March 2020. Heart Failure, 14 publications between 2017 and 2023, average publication date March 2020. Coronary Artery Disease, 19 publications between 2013 and 2024, average publication date April 2020. HIV Infections, 84 publications between 2012 and 2024, average publication date May 2020. Anti-Mullerian Hormone, 1 publications between 2020 and 2020, average publication date July 2020. HIV, 16 publications between 2017 and 2023, average publication date November 2020. Quinolines, 7 publications between 2017 and 2024, average publication date December 2020. Cardiomyopathies, 4 publications between 2019 and 2023, average publication date January 2021. Hydroxymethylglutaryl-CoA Reductase Inhibitors, 10 publications between 2014 and 2024, average publication date January 2021. Cardiovascular Diseases, 29 publications between 2012 and 2024, average publication date March 2021.

To see the data from this visualization as text, click here.
Zanni's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (278)
Explore
_
Co-Authors (68)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.